The American Diabetes Association recommends regular monitoring for patients using these medications
But the impact they create on the budget is still massive
Even though early research shows promise, information is often fragmented or too technical
As individuals can react to medication differently theres no one-size-fits-all answer, but we do have an idea based on clinical studies
Among GLP-1 agents, semaglutide appears to deliver the greatest overall benefit
Weighing Maternal Health Benefits Against Theoretical Risk Untreated obesity during the postpartum period increases maternal risks for type 2 diabetes, cardiovascular disease, and depressionconditions that directly affect breastfeeding success, mood stability, and overall infant care capacity